Background
==========

Patients with small-intestinal polyps are always difficult to treat due to the length, tortuosity, and location of the small bowel. Small-bowel exploration has been drastically revolutionized by device-assisted enteroscopy (DAE) \[[@b1-medscimonit-25-7439]\].

Compared with capsule endoscopy (CE), which is only a diagnostic technique, single-balloon enteroscopy (SBE) and double-balloon enteroscopy (DBE) are used to diagnose and treat diseases of the small intestine, such as Crohn's disease, polypectomy, and bleeding \[[@b2-medscimonit-25-7439]--[@b5-medscimonit-25-7439]\]. Three studies performed meta-analyses to determine the diagnostic and therapeutic yields of DBE and SBE; all 3 studies reported that both DBE and SBE had similar diagnostic and therapeutic fields \[[@b6-medscimonit-25-7439]--[@b8-medscimonit-25-7439]\].

To the best of our knowledge, there are few studies on the role of SBE in adults with small-intestinal polyps in China. In this study, we retrospective studied cases from our medical experience and analyzed the function of SBE and the risk factors of complications after small-intestinal polypectomy.

Material and Methods
====================

All patients who received SBE treatment for small-intestinal polyps found by small-bowel CT scan at Zhejiang Provincial People's Hospital from April 2017 to April 2018 were eligible for the study. Patients were excluded if they had concomitant infection (fever, positive stool culture, positive blood culture, infiltrates on chest x-ray examination, or documented skin infection) before SBE. The clinicopathological factors included age, sex, the route of SBE, CRP tested on the second morning after SBE, polyp number, the max polyp diameter (Dmax), and complications. The endoscopist had already performed about 30 small-bowel polypectomies prior to conducting this study.

Ethical issues
--------------

This study was reviewed and approved by the Institutional Review Board (IRB) of Zhejiang Provincial People's Hospital (approval number KY2018008). Patient identification numbers were used to collect and analyze clinical records. Personal information was anonymized and de-identified prior to analysis.

Single-balloon enteroscopy
--------------------------

All examinations were carried out while patients were under general anesthesia, with endotracheal intubation by Olympus SIF Q260. For both anterograde and retrograde approaches, a standard bowel preparation with polyethylene glycol (30--40 mL/kg/h) was required \[[@b9-medscimonit-25-7439]\]. Adverse effects that occurred within 30 days after the excision of polyps from the small intestine were tracked by weekly telephone contact with the patients' family members.

Statistical analysis
--------------------

All statistical analyses were performed using SPSS 20.0 software. Data are presented as the mean ± standard deviation (SD) or as geometrical means (95% confidence interval \[CI\]) for continuous variables and as percentages for categorical variables. General characteristics were compared among participants with and without CE using the *t* test. Categorical variables were analyzed via the chi-square test. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a logistic analysis of the risks of complications after small-intestinal polypectomy, and receiver operating characteristic (ROC) analysis was used to determine the cut-off points for CRP after small-intestinal polypectomy for postoperative complications. *P* values less than 0.05 were considered statistically significant.

Results
=======

A total of 37 patients were included in the present study. The clinical and demographic characteristics of the patients are shown in [Table 1](#t1-medscimonit-25-7439){ref-type="table"}. The site of polyps was the small bowel. The histology of polyps was hamartoma. We performed 18 anterograde and 19 retrograde approaches, which were all successfully performed. In our research, 16.2% (6/37) of patients had complications after small-intestinal polypectomy: 8.1% (3/37) of patients had bleeding, 8.1% (3/37) of patients had perforation, and 3 patients required emergency surgery after SBE resulting from perforation. During the follow-up, no patients required emergency surgery due to intussusception.

Patients were divided into 2 groups according to the presence of complications after small-intestinal polypectomy. The patients' basic characteristics are shown in [Table 2](#t2-medscimonit-25-7439){ref-type="table"} (characteristic information of the complication group and no complication group after small-intestinal polypectomy). There was no significant difference between the 2 groups based on age, sex, or polyp number (P\>0.05). The max polyp diameter in the complication group (6.0±3.2 cm) was larger than that of the no complication group (3.3±2.2 cm, P\<0.05). CRP in the complication group (87.0±77.2 mg/L) was significantly higher than that of the no complication group (8.3±8.5 mg/L, P\<0.05). We found that Dmax (OR=1.449, 95% CI=1.029--2.041, P\<0.05), and CRP (OR=1.106, 95% CI=1.005--1.218, P\<0.05) were risk factors for fever after small-intestinal polypectomy by univariate logistic analysis, as shown in [Table 3](#t3-medscimonit-25-7439){ref-type="table"}. Multivariate logistic regression showed that CRP (OR 1.104, 95% CI 1.022--1.191, P\<0.05) was the only risk factor that predicted complications.

The ROC curve showed that CRP (≥27.5 mg/dl, AUC=0.858, sensitivity=83.3%, specificity=96.8%), Dmax (≥3.5 cm, AUC=0.750, sensitivity=83.3%, specificity=61.3%), and the combination of CRP+Dmax (AUC=0.984, sensitivity=100%, specificity=96.8%) were all predictors for the complications shown in [Figure 1](#f1-medscimonit-25-7439){ref-type="fig"}.

Discussion
==========

To the best of our knowledge, this study is the first to address the therapeutic efficacy and safety of enteroscopic resection of small-intestinal polyps using SBE in China. [Figure 2](#f2-medscimonit-25-7439){ref-type="fig"} shows the polypectomy operation. In our study, a total of 1081 small-intestinal polyps among 37 patients were removed; the complication rate was 16.2%, which is higher than previous studies reporting a 4.3--13.6% complication rate \[[@b10-medscimonit-25-7439],[@b11-medscimonit-25-7439]\]. This supports the therapeutic efficacy of SBE in treating exceptionally large polyps that are localized in the small intestine. We conclude that SBE could play an important role in small-intestinal polypectomy, which is consistent with a range of previous studies \[[@b5-medscimonit-25-7439],[@b7-medscimonit-25-7439]\]. Our increased complication rate may be due to the larger polyps in our patients. The previous research also showed that polyp size was the only risk for complications \[[@b12-medscimonit-25-7439]\]. It has been recently estimated that the cumulative risk for intussusceptions among patients with Peutz-Jeghers syndrome (PJS) is 33% by age 10 years and 50% by age 20 years due to the small size of intestinal polyps \[[@b13-medscimonit-25-7439]\]. According to our study, SBE may play an important role in small-bowel polyps for patients with PJS. In our study, we found that the maximum diameter of polyps was a risk factor for complications. Therefore, during SBE, the endoscopist should be especially careful if the patient has large small-intestinal polyps. Additionally, CRP, Dmax and the combination of CRP+Dmax are potential markers for predicting complications. For patients with CRP \>27.5 mg/dl and Dmax \>3.5 cm after small-intestinal polypectomy, additional monitoring is necessary to prevent bleeding and perforation.

The present study has several limitations. First, it was a single-center study with a small number of patients. Second, the dedicated endoscopist had technical mastery in performing small-intestinal polypectomy; the availability of equipment and well-trained endoscopists may limit the widespread use of small-intestinal polypectomy.

Conclusions
===========

Single-balloon enteroscopy is an effective endoscopic tool for small-intestinal polypectomy. CRP, Dmax, and the combination of CRP+Dmax may be potential predictors of complications from small-intestinal polypectomy.

**Source of support:** Major Medical Health Science and Technology Project of Zhejiang Province (No. 291825894)
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###### 

Clinical and demographic characteristics of patients.

  Characteristics                
  ------------------------------ -----------
  Patients (n)                   37
  Sex (M: F)                     20: 17
  Age (years)                    35.6±13.0
  Small intestine polyps (n)     29.2±57.2
  Route of SBE (Oral, Anal)(n)   19: 18
  Complications                  6 (16.2%)
  Perforation (n,%)              3 (8.1%)
  Bleeding (n,%)                 3 (8.1%)
  Follow-up (months)             6.9±2.6

SBE -- single-balloon enteroscopy.

###### 

Characteristic information of the complication group and no complication group after small intestinal polypectomy.

                     Complication (n=6)   No complication (n=31)   *P* value
  ------------------ -------------------- ------------------------ -----------
  Age (ys)           28.2±12.7            37.0±12.6                0.14
  Sex (M: F)         3: 3                 17: 14                   0.83
  Polyp number (n)   77.5±80.9            19.9±45.9                0.18
  Dmax (cm)          6.0±3.2              3.3±2.2                  \<0.05
  CRP (mg/L)         87.0±77.2            8.3±8.5                  \<0.05

Dmax -- the max polyp diameter; CRP -- C-reactive protein.

###### 

Logistic analysis of the risks of complications.

         Univariate logistic analysis   Multivariate logistic analysis                          
  ------ ------------------------------ -------------------------------- ---------------------- --------
  Dmax   1.449 (1.029--2.041)           \<0.05                           1.891 (0.983--3.637)   0.06
  CRP    1.106 (1.005--1.218)           \<0.05                           1.104 (1.022--1.191)   \<0.05

Dmax -- the max polyp diameter; CRP -- C-reactive protein.
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